Search Results for keywords:"National Institutes of Health"

The National Institutes of Health (NIH) is holding several closed meetings to review and evaluate grant applications related to various scientific research areas. These meetings will not be open to the public because they will discuss confidential information like trade secrets and personal details related to the grant applicants. The meetings are part of the NIH's efforts to advance studies in fields such as neuroscience and molecular sciences, and they will be conducted virtually. The contact information for the review officers leading each session is provided for those interested in further details.

The National Institutes of Health announced several closed meetings in April 2025 to review and evaluate grant applications. These virtual meetings will gather different committees, such as the Oncology Basic Translational Integrated Review Group and the Cardiovascular and Respiratory Sciences Integrated Review Group, among others. The discussions will be closed to the public to protect confidential information, including trade secrets and personal data. The meetings are conducted under the Federal Advisory Committee Act's provisions, with specific contact persons listed for further inquiries.

The National Institutes of Health (NIH) will hold several closed meetings from mid-April to early May 2025 to review and evaluate grant applications. These meetings are organized by various committees within the Center for Scientific Review. The discussions during the meetings may involve confidential information such as trade secrets or personal details, which is why the meetings are not open to the public. Each meeting will take place virtually, and a specific Scientific Review Officer is assigned to manage each committee.

The National Center for Complementary and Integrative Health is hosting a meeting on April 11th and 14th, 2025, to evaluate grant applications for clinical trials of complementary and integrative interventions. This meeting will be closed to the public to protect confidential information and personal privacy. It will be conducted as a video-assisted meeting, and the address provided is in Bethesda, Maryland. The event is being organized under the Federal Advisory Committee Act.

The National Institutes of Health announced a change to the upcoming meeting of the Etiology, Diagnostic, Intervention and Treatment of Infectious Diseases Study Section, scheduled for May 1-2, 2025, in Bethesda, MD. The meeting notice, initially published on March 11, 2025, has been amended to update the contact person from Dr. Zheng, Liangbiao to Dr. Lewis, Lisa Ann. This meeting will be closed to the public as stated in the amendment.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting to review and evaluate contract proposals. This meeting will involve discussions about confidential trade secrets and personal information, which is why it’s not open to the public. The meeting is scheduled for April 3-4, 2025, from 9:00 a.m. to 6:00 p.m., and will be conducted via video assistance at the NIAID location in Rockville, Maryland. The meeting addresses a solicitation focused on vaccine adjuvant development as part of the Small Business Innovation Research (SBIR) program.

The National Library of Medicine is holding a meeting of its Board of Regents on May 13, 2025. Part of the meeting will be open to the public from 10:00 a.m. to 4:00 p.m. and will focus on program discussions. This meeting will be conducted virtually and can be accessed via the NIH Videocast website. Additionally, a closed session from 4:00 p.m. to 4:30 p.m. will address grant applications, which includes confidential information. Members of the public can submit comments up to 15 days before the meeting.

The National Institutes of Health (NIH) has announced the availability of a government-owned invention for licensing, aimed at speeding up the commercialization of research funded by the government to benefit public health. This invention involves analogues of N-Lactoyl-Phenylalanine (Lac-Phe), which could serve as appetite suppressants and help treat obesity and related diseases. It is currently in the preclinical development stage and is open for licensing under U.S. patent law. Interested parties can contact Malabika Ghosh at the NIH for licensing details.

The Center for Scientific Review announced that it will hold two closed meetings in April 2025 to review and evaluate grant applications. These meetings are not open to the public to protect confidential information such as trade secrets and personal details. The first meeting, concerning Cellular Signaling and Regulatory Systems, is scheduled for April 7-8, while the second, focused on Biobehavioral Medicine and Health Outcomes, will take place from April 9-11. Both meetings will be conducted virtually, and detailed contact information for the respective Scientific Review Officers has been provided.

The National Institute on Alcohol Abuse and Alcoholism is holding two closed meetings to discuss grant applications related to alcohol use disorder treatments and other related research. These meetings are not open to the public to protect sensitive information involving trade secrets, patentable materials, and personal privacy. The first meeting is scheduled for February 26, 2021, and the second for March 15, 2021. Both meetings will be conducted virtually at the National Institute of Health in Bethesda, Maryland.